Clover Health Investments Free Cash Flow 2020-2025 | CLOV
Clover Health Investments free cash flow from 2020 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Clover Health Investments Annual Free Cash Flow | |
|---|---|
| 2024 | 33.29 |
| 2023 | -145.25 |
| 2022 | -208.39 |
| 2021 | -283.05 |
| 2020 | -119.19 |
| 2019 | -159.90 |
| Clover Health Investments Quarterly Free Cash Flow | |
|---|---|
| 2025-03-31 | -16.48 |
| 2024-12-31 | 33.29 |
| 2024-09-30 | 119.44 |
| 2024-06-30 | 69.85 |
| 2024-03-31 | 25.49 |
| 2023-12-31 | -145.25 |
| 2023-09-30 | 112.58 |
| 2023-06-30 | 131.60 |
| 2023-03-31 | 78.78 |
| 2022-12-31 | -208.39 |
| 2022-09-30 | 4.85 |
| 2022-06-30 | -96.54 |
| 2022-03-31 | -57.20 |
| 2021-12-31 | -283.05 |
| 2021-09-30 | -202.64 |
| 2021-06-30 | -157.31 |
| 2021-03-31 | -92.97 |
| 2020-12-31 | -119.19 |
| 2020-09-30 | -59.22 |
| 2020-06-30 | -24.41 |
| 2020-03-31 | -37.42 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.318B | $1.371B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.182B | 58.76 |
| Doximity (DOCS) | United States | $11.140B | 51.57 |
| Hims & Hers Health (HIMS) | United States | $10.623B | 110.37 |
| Tempus AI (TEM) | United States | $10.245B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.558B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.855B | 60.24 |
| Hinge Health (HNGE) | United States | $3.480B | 0.00 |
| Privia Health (PRVA) | United States | $2.672B | 182.67 |
| Enovis (ENOV) | United States | $1.911B | 10.66 |
| Phreesia (PHR) | United States | $1.730B | 0.00 |
| 10x Genomics (TXG) | United States | $1.602B | 0.00 |
| Schrodinger (SDGR) | United States | $1.538B | 0.00 |
| Azenta (AZTA) | United States | $1.504B | 69.89 |
| Omnicell (OMCL) | United States | $1.396B | 24.63 |
| Evolent Health (EVH) | United States | $1.377B | 117.30 |
| Claritev (CTEV) | United States | $0.699B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.612B | 0.00 |
| Veradigm (MDRX) | United States | $0.525B | 0.00 |
| Standard BioTools (LAB) | United States | $0.520B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.440B | 131.50 |
| Outset Medical (OM) | United States | $0.365B | 0.00 |
| TruBridge (TBRG) | United States | $0.340B | 755.33 |
| Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.262B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.168B | 0.00 |
| American Well (AMWL) | United States | $0.134B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.131B | 0.00 |
| Pulmonx (LUNG) | United States | $0.110B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.104B | 3.95 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
| 111 (YI) | China | $0.063B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.049B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |